Clinical trial
Substance Abuse Pre-Treatment Screening Study
NCT00439049 · The University of Texas Health Science Center, Houston, Other · Recruiting
Key facts
| NCT number | NCT00439049 |
|---|---|
| Title | Substance Abuse Pre-Treatment Screening Study |
| Official title | General Evaluation of Eligibility for Substance Abuse/Dependence Research |
| Lead sponsor | The University of Texas Health Science Center, Houston, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Cocaine Abuse, Cocaine Dependence, Opiate Dependence, Alcohol Dependence, Substance Abuse |
| Intervention type | Drug |
| Interventions | modafinil, d-amphetamine, L-Dopa, Naltrexone |
| Enrollment | 7,500 |
| Start date | Oct 1, 2005 |
| Primary completion | Jun 1, 2026 |
| Completion | Jun 1, 2026 |
| First posted | Feb 22, 2007 |
| Last update posted | Dec 20, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: